GUSHENGTANG (02273.HK): Four TCM Clinics Acquired, Not Discloseable
On 5 November 2026, GUSHENGTANG said its units agreed to buy controlling stakes in four TCM clinics for consolidation, none being a discloseable transaction.
Key Highlights:
- The targets provide comprehensive TCM services and will be consolidated into the Group's accounts.
- Subsidiaries agreed to acquire controlling stakes in four TCM clinics in Nanjing and Chengdu.
NewTimeSpace News: On 5 November 2026, Gushengtang Holdings Limited (Stock Code: 2273) announced that its subsidiaries had signed equity transfer contracts to acquire controlling stakes in four TCM clinic operators.
The announcement shows that the target companies are medical institutions providing comprehensive TCM services. The acquisitions fit the Group's strategy of expanding its offline clinic network, adding domestic market share and creating synergies with its other offline clinics and online platform. Consideration was determined after arm's length negotiations with reference to historical performance, qualifications, resources and prospects, and the directors consider the terms fair and reasonable.
- Going Global Weekly Report: Innovative Drugs Win Dense FDA Clearances; SHEIN and Mech-Mind Lead the Hong Kong Listing Wave - 20260828
- GUSHENGTANG (02273.HK): Subsidiary to acquire 100% equity of three TCM clinics in Malaysia, expanding overseas offline network
- Gushengtang (02273.HK): Subsidiary to Acquire Controlling Stakes in Shahe Hospital and Beijing Hongyang Hospital
